Global Arachidonic Acid Market - Strategic Insights and Forecasts (2025-2030)

Description

Arachidonic Acid Market Size:

Global Arachidonic Acid Market is expected to grow at a 4.51% CAGR, increasing to USD 342.327 million by 2030 from USD 274.543 million in 2025.

Arachidonic is a fatty acid that helps in a baby's developing brain. Arachidonic acid (ARA) is a crucial aspect of biological cell membranes because it gives them the fluidity and flexibility necessary for all cells to function properly, especially those in the immune system, skeletal muscle, and neurological systems. It comes from food or linoleic acid undergoing de-saturation and chain elongation. Ion channels, receptors, and enzymes are all affected by free ARA's ability to both activate and inhibit them.

To learn more about this report, request a free sample copy

One of the important Omega-6 fatty acids is arachidonic acid. It is regarded as an essential acid. because it is kept inside cell membranes and guides signals of regenerative changes in response to damaging events. A separate intake of arachidonic acid in injections, syrups, or pills is required due to the body's lack of natural arachidonic acid. The main ingredients used to make ARA are, among others, maize, glucose, soy, and yeast.

There is a rising demand for ARA in dietary supplements as consumers become more health conscious. The probability of physical injuries is anticipated to rise with the popularity of outdoor athletic events like car racing and marathons, which are projected to drive the market in terms of rising application rates and generating revenue. Infant feeding formula penetration is rising, and sports nutrition is also being used more frequently, contributing to the market's expansion. 

Arachidonic Acid Market Growth Drivers:

• Increased use of arachidonic acid in infant formula

The fast technical improvements and new patents filed by the major market players will likely lead to a rise in the use of arachidonic acid in baby feeding during the forecast period. Babies require omega-6 fatty acids since they cannot synthesize the necessary quantity. As a result, the inclusion of ARA in baby food serves to supply the required fatty acids. The main elements that aid in synthesizing cell membranes in developing infants' brains are DHA and arachidonic acid (ARA), a 20-carbon fatty acid. Depending on a mother's diet, the amount of DHA and ARA in breast milk varies greatly between nations.

• Athletics is a key area for the growing demand for ARA.

Arachidonic acid is growing rapidly in the world of athletics. Research on ARA supplements has also been conducted in neurology, hepatology, cardiology, and nutrition. Arachidonic acid regulates inflammation, although there are concerns regarding the risks associated with these supplements. The lean BMI, overall strength, and peak power of trained men may all be improved with ARA supplementation.

• Utilization of ARA-rich oils is a significant demand driver.

The use of ARA-rich oils obtained from the fungus Mortierella Alpina is well known, and the ingredient has long been used in infants and subsequent formulae. According to EU law, oil extracted from Mortierella Alpina is now allowed in infant formula, follow-on formula, and meals for medical purposes for newborns. The German company BASF and the Chinese company Hubei Fuxing Biotechnology are the leading firms producing ARA-rich oils from the fungus Mortierella Alpina.

Arachidonic Acid Market Geographical Outlook:

• North America is projected to be the prominent market throughout the forecast period. 

North America is anticipated to be the largest market for arachidonic acid in food applications, second in Europe and Asia Pacific. The regulatory environment in the EU has helped the local market expand. The demand for ARA in infant formula is growing due to the presence of numerous companies, the intense R&D activities carried out with numerous new patents using ARA for infant formula, as well as sports nutrition, and the rising fertility rate in North America, particularly in Mexico. The current trend of utilizing ARA to treat diabetes is anticipated to aid in expanding the market in additional North American nations.

List of Top Arachidonic Acid Companies:

• Cargill. Inc
• Cabio Biotech (Wuhan) Co., Ltd
• Cayman Chemicals
• Koninklijke DSM N.V.
• Merck Group

Arachidonic Acid Market Segmentation:

• By Source Type
  • Animal-Based
  • Plant-Based
• By Form Type
  • Dry
  • Liquid
• By Application
  • Infant Nutrition
  • Dietary Supplements
  • Pharmaceuticals
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Thailand
    • Others

Table Of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL ARACHIDONIC ACID MARKET BY SOURCE TYPE

5.1. Introduction

5.2. Animal-Based

5.3. Plant-Based

6. GLOBAL ARACHIDONIC ACID MARKET BY FORM TYPE

6.1. Introduction

6.2. Dry

6.3. Liquid

7. GLOBAL ARACHIDONIC ACID MARKET BY APPLICATION

7.1. Introduction

7.2. Infant Nutrition

7.3. Dietary Supplements

7.4. Pharmaceuticals

7.5. Others

8. GLOBAL ARACHIDONIC ACID MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Cargill Incorporated

10.2. Cabio Biotech (Wuhan) Co.., Ltd

10.3. Cayman Chemicals

10.4. DSM-Firmenich

10.5. Merck KgaA

10.6. Avanti Research (Croda International Plc.)

10.7. Guangdong Runke Bioengineering Co., Ltd

10.8. Bio-Techne Corporation

10.9. HiMedia Laboratories LLC

10.10. Tokyo Chemical Industry

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Companies Profiled

Cargill Incorporated

Cabio Biotech (Wuhan) Co.., Ltd

Cayman Chemicals

DSM-Firmenich

Merck KgaA

Avanti Research (Croda International Plc.)

Guangdong Runke Bioengineering Co., Ltd

Bio-Techne Corporation

HiMedia Laboratories LLC

Tokyo Chemical Industry

Related Reports